BZ7A.F Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 апр. 2024 @ 09:24):

Stats
Объем за сегодня	500.00
Средний объем	8.00
Рыночная капитализация	4.85B
EPS	€2.01 ( 2023-06-30 )
Last Dividend	€1.350 ( 2023-08-24 )
Next Dividend	€0 ( N/A )
P/E	29.05
ATR14	€0.0310 (0.50%)

Объем Корреляция

Длинно: -0.05 (neutral)

Кратко: 0.11 (neutral)

Signal:(68.659) Neutral

Bumrungrad Hospital Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Bumrungrad Hospital Корреляция - Валюта/Сырье

0.04
( neutral )

-0.26
( neutral )

-0.23
( neutral )

-0.20
( neutral )

-0.86
( strong negative )

-0.24
( neutral )

Bumrungrad Hospital Финансовые показатели

Annual	2023
Выручка:	€25.38B
Валовая прибыль:	€12.48B (49.19 %)
EPS:	€8.81

FY	2023
Выручка:	€25.38B
Валовая прибыль:	€12.48B (49.19 %)
EPS:	€8.81

FY	2022
Выручка:	€20.72B
Валовая прибыль:	€9.62B (46.43 %)
EPS:	€6.21

Financial Reports:

No articles found.

Bumrungrad Hospital Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€1.150 (N/A)	€0 (N/A)	€2.35 (N/A)	€0 (N/A)	€1.350 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Bumrungrad Hospital Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.74 - Stable (14.87%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.400	2008-04-29
Last Dividend	€1.350	2023-08-24
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	33	--
Total Paid Out	€36.65	--
Avg. Dividend % Per Year	0.00%	--
Score	4.08	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.74
Div. Directional Score	9.18	--

Next Divdend (Est)
(2024-06-21)

€1.337 Estimate 7.54 %

Dividend Stability

0.30 Poor

Dividend Score

4.08

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
TTK.DE	Ex Dividend Junior	2023-05-25	Annually	0.00%
DWD.DE	Ex Dividend Junior	2023-07-28	Quarterly	0.00%
MZX.DE	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
8TRA.DE	Ex Dividend Junior	2023-06-02	Annually	0.00%
XGR2.DE	Ex Dividend Junior	2023-06-08	Annually	0.00%
FPMB.DE	Ex Dividend Knight	2023-10-12	Quarterly	0.00%
PFE.DE	Ex Dividend Knight	2023-07-27	Quarterly	0.00%
ASME.DE	Ex Dividend Knight	2023-08-01	Semi-Annually	0.00%
HNR1.DE	Ex Dividend Junior	2023-05-04	Annually	0.00%
SDF.DE	Ex Dividend Junior	2023-05-11	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.287	1.500	4.27	6.40	[0 - 0.5]
returnOnAssetsTTM	0.237	1.200	2.08	2.50	[0 - 0.3]
returnOnEquityTTM	0.319	1.500	7.56	10.00	[0.1 - 1]
payoutRatioTTM	0.397	-1.000	6.03	-6.03	[0 - 1]
currentRatioTTM	4.29	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.16	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.639	1.500	7.56	10.00	[0.2 - 2]
debtRatioTTM	0.00473	-1.500	9.92	-10.00	[0 - 0.6]
interestCoverageTTM	2 236.39	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	9.62	2.00	6.79	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.40	2.00	6.30	10.00	[0 - 20]
debtEquityRatioTTM	0.00572	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.501	1.000	4.98	4.98	[0.2 - 0.8]
operatingProfitMarginTTM	0.348	1.000	5.05	5.05	[0.1 - 0.6]
cashFlowToDebtRatioTTM	51.77	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.828	0.800	7.81	6.25	[0.5 - 2]
Total Score				12.62

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.71	1.000	7.50	0	[1 - 100]
returnOnEquityTTM	0.319	2.50	8.43	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.40	2.00	7.53	10.00	[0 - 30]
dividendYielPercentageTTM	1.878	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	9.62	2.00	6.79	10.00	[0 - 30]
payoutRatioTTM	0.397	1.500	6.03	-6.03	[0 - 1]
pegRatioTTM	0.0775	1.500	-2.82	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.296	1.000	5.11	0	[0.1 - 0.5]
Total Score				5.74

Bumrungrad Hospital

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.